Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Atossa Therapeutics logo — Providing innovative treatments for pre-cancerous breast con...

Atossa Therapeutics

Providing innovative treatments for pre-cancerous breast conditions and early-stage breast cancer.

Founded 2009 51-200 employees Post Ipo Equity Total: $57.80M Biotechnology, Health Care +1

General Information

Company Name Atossa Therapeutics
Founded Year 2009
Employees 51-200
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when Atossa Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Atossa Therapeutics

Atossa Therapeutics is a clinical-stage biopharmaceutical company established in 2009 with a mission to provide innovative treatments for pre-cancerous breast conditions and early-stage breast cancer. Their slogan, "Providing innovative treatments for pre-cancerous breast conditions and early-stage breast cancer," reflects their dedication to addressing critical unmet medical needs in the field of Biotechnology and Health Care. The company recently secured a notable $25.20M in Post-IPO Equity investment on 01 January 2021, showcasing investor confidence in their research and development efforts. As a potential investment opportunity, Atossa Therapeutics presents an intriguing proposition within the biopharmaceutical sector. Their focus on addressing breast cancer and related conditions aligns with market needs, and the recent investment reaffirms investor interest and support in the company's initiatives. Therefore, this company warrants a closer examination for venture capital firms seeking exposure to innovative advancements in the healthcare industry.

Taxonomy: Biopharmaceutical, Clinical-stage, Breast cancer treatment, Innovative treatments, Molecular diagnostics, Pre-cancerous breast conditions, Early-stage breast cancer, Medical research, Cancer therapeutics

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 01 Jan 2021
Post-IPO Equity •••••• 1
Investor
28 May 2015
Post-IPO Equity •••••• - 11 Apr 2013
Venture Round •••••• - 27 Jun 2011
Venture Round •••••• 1
Investor
01 Jan 2011

Atossa Therapeutics Alternatives & Competitors

Atossa Therapeutics vs
Cianna Medical
Cianna Medical

Pioneering Women's Health: Advancing Breast Conservation Therapy for Early-Stage Breast Cancer

Series Unknown
Health Care, Medical Devices
Atossa Therapeutics vs
Aragon Pharmaceuticals
Aragon Pharmaceuticals

Pioneering breakthrough treatments for hormone-resistant prostate and breast cancers.

Series D
Biotechnology, Health Care
Atossa Therapeutics vs
HAVAH Therapeutics
HAVAH Therapeutics Australia

Developing prevention and early treatment options for hormonally driven breast cancer and other brea...

Series Unknown
5 employees
Biotechnology, Health Care

FAQ About Atossa Therapeutics

Providing innovative treatments for pre-cancerous breast conditions and early-stage breast cancer.
Atossa Therapeutics was founded in 2009.
Atossa Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Atossa Therapeutics has approximately 51-200 employees.
Atossa Therapeutics has completed 5 funding rounds, raising a total of $57.80M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Atossa Therapeutics include Cianna Medical, Aragon Pharmaceuticals, HAVAH Therapeutics, Delphi Diagnostics Inc., Advanced Radiation Therapy. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Atossa Therapeutics and Cianna Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Atossa Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy